Authors' reply

Affiliations

¹ Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.
² Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
³ Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
⁴ Department of Clinical Oncology, United Christian Hospital, Kwun Tong, Hong Kong.

Comment

W Yeo et al. Hong Kong Med J. 2017 Jun.

. 2017 Jun;23(3):315-6.

¹ Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.
² Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
³ Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.
⁴ Department of Clinical Oncology, United Christian Hospital, Kwun Tong, Hong Kong.

No abstract available

Comment on

Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors.
Yeo W, Lam KO, Law AL, Lee CC, Chiang CL, Au KH, Mo FK, So TH, Lam KC, Ng WT, Li L. Yeo W, et al. Hong Kong Med J. 2017 Feb;23(1):54-62. doi: 10.12809/hkmj164885. Epub 2016 Dec 14. Hong Kong Med J. 2017. PMID: 27966431
Adjuvant S-1 chemotherapy after curative resection of gastric cancer.
Leung JS. Leung JS. Hong Kong Med J. 2017 Jun;23(3):315. doi: 10.12809/hkmj176283. Hong Kong Med J. 2017. PMID: 28572524 No abstract available.